NGEN

NervGen Pharma
NGEN

44 hedge funds and large institutions have $6.39M invested in NervGen Pharma in 2026 Q1 according to their latest regulatory filings, with 44 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
44
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$7K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$871K
2
+$869K
3
+$868K
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$745K
5
IWC
Integrated Wealth Concepts
Massachusetts
+$376K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Mariner
26
Mariner
Kansas
$67.4K
T. Rowe Price Associates
27
T. Rowe Price Associates
Maryland
$59K
LPL Financial
28
LPL Financial
California
$50.5K
SC
29
Scotia Capital
Ontario, Canada
$49.1K
Creative Planning
30
Creative Planning
Kansas
$48.8K
Morgan Stanley
31
Morgan Stanley
New York
$45.2K
ATPW
32
Ashton Thomas Private Wealth
Arizona
$40.3K
CIBC World Market
33
CIBC World Market
Ontario, Canada
$39.8K
FLPIM
34
F.L. Putnam Investment Management
Massachusetts
$38.5K
DOA
35
D'Orazio & Associates
Virginia
$37.7K
APW
36
Aventura Private Wealth
Florida
$25.9K
AF
37
Allworth Financial
California
$22.6K
SPIA
38
Steward Partners Investment Advisory
New York
$15.5K
SAM
39
Smartleaf Asset Management
Massachusetts
$13.6K
Jones Financial Companies
40
Jones Financial Companies
Missouri
$3.66K
National Bank of Canada
41
National Bank of Canada
Quebec, Canada
$3.13K
MCM
42
MAI Capital Management
Ohio
$2.64K
Simplex Trading
43
Simplex Trading
Illinois
$101
CIAM
44
Caitong International Asset Management
Hong Kong
$4
1
2